Medical Isotope
Radiopharmaceuticals
GMP & GLP Solutions
Cancer Diagnosis & Treatment
About us
Careers
News & Events
Company News Industry Information
Contact
Language
EN CN
Home · News & Events

Industry Information

Molecular Targeting Technologies Presents First Clinical Validation of the Evans Blue Platform, Demonstrating Up to 15-Day Tumor Retention Using Approximately 12.5% of the Radioactivity Required for Conventional PRRT

View more
Jul 10, 2026

Defence Therapeutics Opens New Office in Hamilton to Expand Its Accum Radiopharmaceutical Platform

View more
Jul 10, 2026

New approach could expand CAR T therapy from blood cancers to solid tumors

View more
Jul 09, 2026

PET/MRI can reduce the need for biopsies in prostate cancer

View more
Jul 06, 2026

Production problems hamper Lantheus bid for FDA approval of radiopharma dx kit

View more
Jul 02, 2026

PET/CT guides treatment in men with recurrent prostate cancer

View more
Jul 01, 2026
...45678910...